A detailed history of M&G PLC transactions in Boston Scientific Corp stock. As of the latest transaction made, M&G PLC holds 131,872 shares of BSX stock, worth $13.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
131,872
Previous 24,018 449.05%
Holding current value
$13.5 Million
Previous $2.58 Million 399.19%
% of portfolio
0.08%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$97.03 - $108.14 $10.5 Million - $11.7 Million
107,854 Added 449.05%
131,872 $12.9 Million
Q2 2025

Aug 08, 2025

BUY
$89.7 - $107.41 $6,189 - $7,411
69 Added 0.29%
24,018 $2.58 Million
Q1 2025

May 13, 2025

BUY
$89.38 - $106.18 $724,961 - $861,225
8,111 Added 51.21%
23,949 $2.42 Million
Q4 2024

Feb 11, 2025

BUY
$83.62 - $91.5 $3,595 - $3,934
43 Added 0.27%
15,838 $1.41 Billion
Q3 2024

Oct 31, 2024

BUY
$72.96 - $84.0 $1.15 Million - $1.33 Million
15,795 New
15,795 $1.33 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track M&G PLC Portfolio

Follow M&G PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G PLC, based on Form 13F filings with the SEC.

News

Stay updated on M&G PLC with notifications on news.